Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100146652 Xenobiotic related induction of gene expression
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145033 Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
06/10/2010US20100145032 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
06/10/2010US20100145030 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/10/2010US20100145027 Compositions and Methods for the Diagnosis and Treatment of Tumor
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100145021 Process for enhancing protein recovery yields
06/10/2010US20100145020 Method for producing high-purity soluble thrombomodulin
06/10/2010US20100145019 Dispersion improver for gluten, and dispersion solution of gluten
06/10/2010US20100145018 Lipid-Polymer-Conjugates
06/10/2010US20100145017 Method of producing interferon-b complex
06/10/2010US20100145016 Compositions and methods for purifying calreticulin
06/10/2010US20100145015 Compositions and methods for increasing immunogenicity of glycoprotein vaccines
06/10/2010US20100145012 Anti-cancer bioactive peptide
06/10/2010US20100145011 Alpha-conotoxin peptides
06/10/2010US20100145010 Functional enhancement of antimicrobials
06/10/2010US20100145009 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use
06/10/2010US20100145008 Ob-fold used as scaffold for engineering new specific binders
06/10/2010US20100145007 Chimeric peptide antagonist for gpcr135 or gpcr142
06/10/2010US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144832 Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144642 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
06/10/2010US20100144640 Molecules designated b7l-1
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144628 Hepatopoietin and use thereof
06/10/2010US20100144623 C-Terminal Domain Truncation of mGluR1a By Calpain and Uses Thereof
06/10/2010US20100144622 Methods for production of recombinant plasminogen and plasmin polypeptides
06/10/2010US20100144619 Antimicrobial Protein Specific to Staphylococcus Aureus
06/10/2010US20100144617 Oxyntomodulin Derivatives
06/10/2010US20100144615 Nucleotide sequence encoding a modulator of nf-kb
06/10/2010US20100144605 Rescue of gonadotropin releasing hormone receptor mutants
06/10/2010US20100144603 Methods and uses thereof of prosaposin
06/10/2010US20100144600 Osteoprotegerin variant proteins
06/10/2010US20100144598 Natural Polypeptides For Oral Health Care
06/10/2010US20100144596 An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100144041 for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes; polynucleotide encoding an isolated non-conventional yeast arabinose transporter; biofuels
06/10/2010US20100144039 Pluripotency determining factors and uses thereof
06/10/2010US20100144038 Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell
06/10/2010US20100144027 Placental protein having a regulating action on proteolytic activity and its related gene
06/10/2010US20100143989 Production Of 3-Hydroxycarboxylic Acid Using Nitrilase Mutants
06/10/2010US20100143973 Interleukin-11 Fusion Proteins
06/10/2010US20100143942 Method of detection
06/10/2010US20100143936 Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof
06/10/2010US20100143927 Methods and Assays for Measuring p95 and/or p95 in a Sample and Antibodies Specific for p95
06/10/2010US20100143918 Translocation and mutant ros kinase in human non-small cell lung carcinoma
06/10/2010US20100143890 Peptide compounds for capturing or inhibiting avian influenza virus and application thereof
06/10/2010US20100143884 Detection of influenza virus
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143442 Growth factor complexes and modulation of cell migration and growth
06/10/2010US20100143438 Biomolecules
06/10/2010US20100143433 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
06/10/2010US20100143424 Casein nanoparticle
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143411 Method for identification of t-lymphocyte antigens
06/10/2010US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/10/2010US20100143409 Generation of virus-like particles and use as panfilovirus vaccines
06/10/2010US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
06/10/2010US20100143395 Material with immunogenicity
06/10/2010US20100143394 Synthetic streptococcus pneumoniae vaccine
06/10/2010US20100143393 Novel influenza m2 vaccines
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143357 Uses of Mammalian Cytokine; Related Reagents
06/10/2010US20100143342 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
06/10/2010US20100143336 Toll-like receptor binding epitope and compositions for binding thereto
06/10/2010US20100143335 Treating atherosclerosis
06/10/2010US20100143330 Methods of treating disorders associated with fat storage
06/10/2010US20100143315 Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143310 SPINAL NERVE REPAIR PROMOTING THERAPEUTICS CONTAINING GHRELIN OR ITS DERIVATIVES OR SUBSTANCES THAT ACT ON GHS-R1a AS AN ACTIVE INGREDIENT
06/10/2010US20100143308 Akt nucleic acids, polypeptides, and uses thereof
06/10/2010US20100143298 Colloidal metal compositions and methods
06/10/2010US20100143293 T cell activation
06/10/2010US20100143292 Il-21 variants
06/10/2010US20100143288 Human granulocyte-colony stimulating factor isoforms
06/10/2010US20100143262 Method for Identifying Allergenic Proteins And Peptides
06/10/2010DE4419264B4 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections
06/10/2010CA2745838A1 Plant growth promoting protein complex
06/10/2010CA2745798A1 Blocking mesothelin peptide fragments
06/10/2010CA2745608A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/10/2010CA2745603A1 Use of phenol soluble modulins for the development of vaccines
06/10/2010CA2745527A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010CA2745499A1 Peptide therapeutic conjugates and uses thereof
06/10/2010CA2745470A1 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
06/10/2010CA2745329A1 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
06/10/2010CA2745259A1 Novel method for generation of rna virus
1 ... 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 ... 2916